{"id":"https://openalex.org/W2267658482","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.9500","title":"Lexatumumab: Results of a phase I trial in pediatric patients with advanced solid tumors.","display_name":"Lexatumumab: Results of a phase I trial in pediatric patients with advanced solid tumors.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2267658482","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.9500","mag":"2267658482"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.9500","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.9500","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.9500","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003587544","display_name":"Mythili Merchant","orcid":"https://orcid.org/0000-0002-2061-1306","observed_orcids":["https://orcid.org/0000-0002-2061-1306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. S. Merchant","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006444409","display_name":"Alexander J. Chou","orcid":"https://orcid.org/0000-0002-7926-3326","observed_orcids":["https://orcid.org/0000-0002-7926-3326"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. J. Chou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001992755","display_name":"Anita P. Price","orcid":"https://orcid.org/0000-0002-3917-6666","observed_orcids":["https://orcid.org/0000-0002-3917-6666"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Price","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074724246","display_name":"James I. Geller","orcid":"https://orcid.org/0000-0001-5181-116X","observed_orcids":["https://orcid.org/0000-0001-5181-116X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. I. Geller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059497696","display_name":"Maria Tsokos","orcid":"https://orcid.org/0000-0001-8072-1358","observed_orcids":["https://orcid.org/0000-0001-8072-1358"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Tsokos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074231558","display_name":"Charles H. Graham","orcid":"https://orcid.org/0000-0002-7014-8639","observed_orcids":["https://orcid.org/0000-0002-7014-8639"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Graham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005322109","display_name":"Ava Charles","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Charles","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010913859","display_name":"Paul A. Meyers","orcid":"https://orcid.org/0000-0001-6146-6101","observed_orcids":["https://orcid.org/0000-0001-6146-6101"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. A. Meyers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5087779758","display_name":"Crystal Lee Mackall","orcid":"https://orcid.org/0000-0003-0359-9023","observed_orcids":["https://orcid.org/0000-0003-0359-9023","https://orcid.org/0000-0001-6323-4304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Mackall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"9500","last_page":"9500"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.33180001378059387,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.33180001378059387,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.10859999805688858,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0835999995470047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lexatumumab","display_name":"lexatumumab","score":1.0},{"id":"https://openalex.org/keywords/pediatric-solid-tumors","display_name":"pediatric solid tumors","score":0.7009999752044678},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7540000081062317},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9549999833106995},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7889999747276306},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.9559999704360962},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8090000152587891},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.8539999723434448},{"id":"https://openalex.org/keywords/hepatoblastoma","display_name":"hepatoblastoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9561811685562134},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.573354184627533},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45630472898483276},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4557679295539856},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.45154568552970886},{"id":"https://openalex.org/C2776304256","wikidata":"https://www.wikidata.org/wiki/Q1607658","display_name":"Hepatoblastoma","level":2,"score":0.4430141746997833},{"id":"https://openalex.org/C2993561819","wikidata":"https://www.wikidata.org/wiki/Q5097977","display_name":"Pediatric cancer","level":3,"score":0.4138389229774475},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4020988345146179},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3719028830528259},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3579753339290619},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2911030650138855},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.18490689992904663}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.9500","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.9500","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.9500","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2119199226","https://openalex.org/W7222794412","https://openalex.org/W2138393270","https://openalex.org/W2336753878","https://openalex.org/W1934014346","https://openalex.org/W2602459439","https://openalex.org/W2129003087","https://openalex.org/W2145088312","https://openalex.org/W1931737153","https://openalex.org/W2774516270"],"abstract_inverted_index":{"9500":[0],"Background:":[1],"Lexatumumab":[2,208,236],"is":[3,237],"an":[4],"agonist,":[5],"fully-human":[6],"monoclonal":[7],"antibody":[8],"against":[9],"TNF-Related":[10],"Apoptosis":[11],"Inducing":[12],"Ligand":[13],"Receptor":[14],"2":[15,67,106,176],"(TRAIL-R2)":[16],"with":[17,34,76,179,190,201,215,230],"preclinical":[18],"evidence":[19],"of":[20,42,63,86,140,143,196],"activity":[21,224],"in":[22,31,92,164,227,248,261],"several":[23],"pediatric":[24,50,249],"solids":[25],"tumors.":[26,81],"A":[27],"phase":[28,51],"I":[29],"trial":[30],"adult":[32],"patients":[33,70,136,166,252],"solid":[35,80],"tumors":[36],"revealed":[37],"a":[38,93,138,186,228],"maximum":[39,122,257],"tolerated":[40,123,239,258],"dose":[41,53,124,149,259],"10mg/kg":[43,155,209],"IV":[44],"every":[45,66,105,245],"14":[46,246],"days.":[47],"Methods:":[48],"This":[49],"I,":[52],"escalation":[54],"study":[55,197],"examined":[56],"the":[57,121,193,256],"safety,":[58],"tolerability,":[59],"pharmacokinetics,":[60],"and":[61,74,129,154,182,218,232,240],"immunogenicity":[62],"lexatumumab":[64,87,144],"administered":[65,244],"weeks":[68],"to":[69,145,169,267],"21":[71],"years":[72],"old":[73],"younger":[75],"recurrent":[77],"or":[78,114],"progressive":[79],"Patient":[82],"received":[83,137],"increasing":[84],"doses":[85,212],"(3,":[88,151],"5,":[89,152],"8,":[90,153],"10mg/m2)":[91],"3":[94,96,168,188],"+":[95],"design.":[97],"Tumors":[98],"were":[99],"measured":[100],"after":[101],"4":[102,148],"weeks,":[103],"then":[104],"months.":[107],"Treatment":[108],"was":[109,225],"continued":[110],"until":[111],"disease":[112,162,217],"progression":[113],"unacceptable":[115],"toxicity.":[116],"The":[117],"expanded":[118],"cohort":[119],"at":[120,210],"included":[125],"6":[126,130],"children":[127],"(2-12yo)":[128],"adolescents":[131],"(13-21yo).":[132],"Results:":[133],"Twenty":[134],"four":[135],"total":[139],"57":[141],"cycles":[142],"date":[146],"over":[147],"levels":[150],"q14days;":[156],"1":[157],"cycle":[158,195],"=":[159],"28days).":[160],"Stable":[161],"occurred":[163],"5":[165],"for":[167],"17":[170],"cycles.":[171],"One":[172,199],"patient":[173,184,200,229],"had":[174],"grade":[175,187],"pericarditis":[177],"consistent":[178],"radiation":[180],"recall,":[181],"one":[183],"developed":[185],"pneumonia":[189],"hypoxia":[191],"during":[192],"second":[194],"drug.":[198],"unresectable":[202],"osteosarcoma":[203],"pulmonary":[204],"metastases":[205],"continues":[206],"on":[207],"35+":[211],"(17+":[213],"cycles)":[214],"stable":[216],"marked":[219],"clinical":[220,223],"improvement.":[221],"Transient":[222],"observed":[226],"hepatoblastoma":[231],"Ewing":[233],"sarcoma.":[234],"Conclusions:":[235],"well":[238],"can":[241],"be":[242],"safely":[243],"days":[247],"patients.":[250],"Pediatric":[251],"tolerate":[253],"10":[254],"mg/kg,":[255],"identified":[260],"adults.":[262],"No":[263],"significant":[264],"financial":[265],"relationships":[266],"disclose.":[268]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}